Category Archives: Interventional Cardiology

Doctors learning about COVID-19s effects on the body are seeing signs of lasting damage in the heart that does not appear to be impacting overall wellness. Doctors learning about COVID-19s effects on the body are seeing signs of lasting damage in the heart that does not appear to be impacting overall wellness Continue reading →

While edoxaban features a positive risk-benefit ratio when compared to conventional therapy with warfarin in treating venous thromboembolism (VTE), the efficacy and safety of the medication is not yet understood during the highest risk period in this patient population. Continue reading →

This Pediatric Interventional Cardiology Devices Market report offers a detailed view of market opportunity by end user segments, product segments, sales channels, key countries, and import / export dynamics. It details market size & forecast, growth drivers, emerging trends, market opportunities, and investment risks in over various segments in Pediatric Interventional Cardiology Devices industry. Continue reading →

The contrast media injector market is projected to grow at a CAGR of 7. 4% during the forecast period Continue reading →

BATON ROUGE Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Niksad Abraham was the first to use the AMPLATZERTMSeptal Occluderdevice for the closure of atrial septal defects at Baton Rouge General Continue reading →

Reportspedia presents the intelligent report title as Pediatric Interventional Cardiology Equipment Market Covid-19 Impact Global Analysis and Forecasts by product, application, and end-user. This Market is expected to provide numerous growth opportunities across the worldwide also comprehensive and an all-inclusive method for the analysis and determination of the factors which are likely to have an impact on the growth of the market in the estimated anticipate period. Continue reading →

The number of PCIs performed in the United States and Japan is up in recent years, more so in Japan, but the types of cases driving the increase differs between the two countries, according to a new comparative analysis of temporal trends in PCI volume. In Japan, the increase in PCIs was driven by a rise in elective cases, whereas the bump in volume stateside was mainly the result of an increase in nonelective PCIs, report investigators. Stress testing, mainly myocardial perfusion imaging, was far more common in the United States, while coronary CT angiography (CTA) was the most common imaging test used prior to PCI in Japan Continue reading →

Latest Research Study on Global 19 Impact on Global Interventional Cardiology Market, offers a detailed overview of the factors influencing the global business scope. Global 19 Impact on Global Interventional Cardiology Market research report shows the latest market insights with upcoming trends and breakdown of the products and services Continue reading →

PETOSKEY, Mich.--(BUSINESS WIRE)--BioStar Capital, a value-add investment firm focused on transformational medical device technologies that serve unmet patient needs in cardiovascular and orthopedic medicine, today announced that Mark Toland, former CEO of Corindus Vascular Robotics, a Siemens Healthineers and BioStar portfolio company, has joined the firm as a partner and entrepreneur in residence (EIR). In this role, Mark will help BioStar discover, develop and nurture new startups with transformative, high-growth potential. Continue reading →

Jaipur, Rajasthan, India (NewsVoir) Both the heart valves of the patient were severely diseased. The patient was suffering from severe aortic and mitral stenosis and severe mitral annular calcification. He was deemed extremely high risk for surgery and was denied surgery at all major hospitals of the country. Continue reading →